Literature DB >> 21466663

Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro.

Stephanie Ghislin1, Dorian Obino, Sandrine Middendorp, Nicole Boggetto, Catherine Alcaide-Loridan, Frederique Deshayes.   

Abstract

One of the main steps of metastasis is extravasation, a phenomenon well described in lymphocytes but remaining to be fully uncovered for melanoma. Junctional adhesion molecules (JAMs) control the transendothelial migration of leukocytes. To date, the role of the JAM proteins, notably JAM-A and JAM-C, has not been examined in melanoma. Here, we compared two melanoma tumor cell lines, A375 and SLM8 cells, the A375 cell line being four times more efficient than the SLM8 cells in the crossing of the endothelial monolayer. We show evidence of the differential expression of JAM-A and JAM-C in these cell lines with JAM-C mainly expressed in the A375 cell line, and JAM-A detected preferentially in the SLM8 cells. To further dissect the respective roles of these proteins, we used both siRNA and blocking antibodies to decrease JAM-A and JAM-C expression. 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21466663     DOI: 10.1111/j.1755-148X.2011.00856.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  18 in total

1.  Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.

Authors:  Aurelie Borrull; Stephanie Ghislin; Frederique Deshayes; Jessica Lauriol; Catherine Alcaide-Loridan; Sandrine Middendorp
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-11       Impact factor: 4.553

Review 2.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 3.  Dysregulation of JAM-A plays an important role in human tumor progression.

Authors:  Chen Zhao; Funian Lu; Hongxia Chen; Xianda Zhao; Jun Sun; Honglei Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in BrafV600E/PtenNULL Mice.

Authors:  Gagan Chhabra; Chandra K Singh; Glorimar Guzmán-Pérez; Mary A Ndiaye; Kenneth A Iczkowski; Nihal Ahmad
Journal:  J Invest Dermatol       Date:  2021-09-29       Impact factor: 7.590

Review 5.  Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis.

Authors:  Astrid O Leech; Rodrigo G B Cruz; Arnold D K Hill; Ann M Hopkins
Journal:  Ann Transl Med       Date:  2015-08

6.  Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa.

Authors:  Laudine Communal; Mauricio Medrano; Fabrice Sircoulomb; Joshua Paterson; Martin Köbel; Kurosh Rahimi; Paul Hoskins; Dongsheng Tu; Stephanie Lheureux; Amit Oza; Laurie Ailles; Diane Provencher; Robert Rottapel; Anne-Marie Mes-Masson
Journal:  Mod Pathol       Date:  2020-06-08       Impact factor: 7.842

7.  Nectin-3 (CD113) interacts with Nectin-2 (CD112) to promote lymphocyte transendothelial migration.

Authors:  Elisabeth Devilard; Luc Xerri; Patrice Dubreuil; Marc Lopez; Nicolas Reymond
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

Review 8.  Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression.

Authors:  Adam Lauko; Zhaomei Mu; Ulhas P Naik; Justin D Lathia; David H Gutmann
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

9.  LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitro.

Authors:  Stephanie Ghislin; Dorian Obino; Sandrine Middendorp; Nicole Boggetto; Catherine Alcaide-Loridan; Frederique Deshayes
Journal:  BMC Cancer       Date:  2012-10-05       Impact factor: 4.430

Review 10.  Tight junction proteins in gastrointestinal and liver disease.

Authors:  Mirjam B Zeisel; Punita Dhawan; Thomas F Baumert
Journal:  Gut       Date:  2018-10-08       Impact factor: 31.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.